Nano Holdings, Inc.
Research Nano Holdings, Inc. (4571.T) on Bullrun: market cap JPY 7.45B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4571.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 7.45B
- Financial periodFY2026
- RevenueJPY 174.50M
- Revenue growth60.8%
- Net income-JPY 943.88M
- Free cash flow-JPY 816.67M
- Gross margin87.8%
Valuation Snapshot
latest market cap is JPY 7.45B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 174.50M | -JPY 943.88M | -JPY 816.67M | 87.8% | -12.9 | JPY 4.91B | JPY 1.60B | JPY 3.57B |
| FY2025 | JPY 108.52M | -JPY 835.38M | -JPY 401.62M | 72.0% | -11.85 | JPY 1.71B | JPY 540.24M | JPY 2.74B |
| FY2024 | JPY 135.51M | -JPY 780.00M | -JPY 585.08M | 81.9% | -11.1 | JPY 2.08B | JPY 1.11B | JPY 3.42B |
| FY2023 | JPY 202.19M | -JPY 1.31B | -JPY 1.09B | 78.9% | -18.7 | JPY 2.81B | JPY 1.11B | JPY 4.25B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 7.45B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Nano Holdings, Inc.
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nano Holdings, Inc.'s market cap?
Nano Holdings, Inc.'s market capitalization is JPY 7.45B.
What does Nano Holdings, Inc. do?
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.